<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940627-0-00251</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4700 -->  <!-- PJG ITAG l=11 g=1 f=1 --> (3)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Analysis.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Slides shall be coded for study before  <!-- PJG 0012 frnewline --> microscopic analysis. At least 1,000 first-division erythrocytes  <!-- PJG 0012 frnewline --> per animal shall be scored for the incidence of micronuclei.  <!-- PJG 0012 frnewline --> Sexes will be analyzed separately.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (e)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Data and report_ <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> (1)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Treatment of results.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> In addition to the reporting  <!-- PJG 0012 frnewline --> requirements specified under &sect;&sect;79.60 and 79.61, the final test  <!-- PJG 0012 frnewline --> report must include the criteria for scoring micronuclei.  <!-- PJG 0012 frnewline --> Individual data shall be presented in a tabular form including  <!-- PJG 0012 frnewline --> both positive and negative controls and experimental groups. The  <!-- PJG 0012 frnewline --> number of polychromatic erythrocytes scored, the number of  <!-- PJG 0012 frnewline --> micronucleated erythrocytes, the percentage of micronucleated  <!-- PJG 0012 frnewline --> cells, and, where applicable, the percentage of micronucleated  <!-- PJG 0012 frnewline --> erythrocytes shall be listed separately for each experimental and  <!-- PJG 0012 frnewline --> control animal. Absolute numbers shall be included if  <!-- PJG 0012 frnewline --> percentages are reported.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (2)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Interpretation of data.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> (i) There are several criteria for determining a positive  <!-- PJG 0012 frnewline --> response, one of which is a statistically significant  <!-- PJG 0012 frnewline --> dose-related increase in the number of micronucleated  <!-- PJG 0012 frnewline --> polychromatic erythrocytes. Another criterion may be based upon  <!-- PJG 0012 frnewline --> detection of a reproducible and statistically significant  <!-- PJG 0012 frnewline --> positive response for at least one of the test substance  <!-- PJG 0012 frnewline --> concentrations.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  (ii) A test substance which does not produce either a  <!-- PJG 0012 frnewline --> statistically significant dose-related increase in the number of  <!-- PJG 0012 frnewline --> micronucleated polychromatic erythrocytes or a statistically  <!-- PJG 0012 frnewline --> significant and reproducible positive response at any one of the  <!-- PJG 0012 frnewline --> test points is considered nonmutagenic in this system.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (3)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Test evaluation.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> (i) Positive results in the micronucleus test provide  <!-- PJG 0012 frnewline --> information on the ability of a chemical to induce micronuclei in  <!-- PJG 0012 frnewline --> erythrocytes of the test species under the conditions of the  <!-- PJG 0012 frnewline --> test. This damage may have been the result of chromosomal damage  <!-- PJG 0012 frnewline --> or damage to the mitotic apparatus.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (ii) Negative results indicate that under the test  <!-- PJG 0012 frnewline --> conditions the test substance does not produce micronuclei in the  <!-- PJG 0012 frnewline --> bone marrow of the test species.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (f)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Test report.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> In addition to the reporting  <!-- PJG 0012 frnewline --> recommendations as specified under &sect;79.60, the following  <!-- PJG 0012 frnewline --> specific information shall be reported:  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (1) Test atmosphere concentration(s) used and rationale for  <!-- PJG 0012 frnewline --> concentration selection.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (2) Rationale for and description of treatment and sampling  <!-- PJG 0012 frnewline --> schedules, toxicity data, negative and positive controls.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (3) Historical control data (negative and positive), if  <!-- PJG 0012 frnewline --> available.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (4) Details of the protocol used for slide preparation.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (5) Criteria for identifying micronucleated erythrocytes.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (6) Micronucleus analysis by animal and by group for each  <!-- PJG 0012 frnewline --> concentration (sexes analyzed separately).  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (i) Ratio of polychromatic to normochromatic erythrocytes.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (ii) Number of polychromatic erythrocytes with micronuclei.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (iii) Number of polychromatic erythrocytes scored.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (7) Statistical methodology chosen for test analysis.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (g)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> References.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> For additional background information on  <!-- PJG 0012 frnewline --> this test guideline, the following references should be  <!-- PJG 0012 frnewline --> consulted.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 --> (1) 40 CFR 798.5395,  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> In Vivo,  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> Mammalian Bone Marrow  <!-- PJG 0012 frnewline --> Cytogenetics Tests: Micronucleus Assay.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (2) Cihak, R. ``Evaluation of Benzidine by the Micronucleus  <!-- PJG 0012 frnewline --> Test.'' Mutation Research, 67: 383&hyph;384 (1979).  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            